While pharmacologic therapies remain central to managing PsO and PsA, non-pharmacologic interventions also play a crucial ...

The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Several characteristics, including BMI and Charlson Comorbidity Index, were associated with super response to biologics in patients with psoriasis.

Less than a quarter of patients diagnosed with mild psoriasis had a body surface area of less than 3% at the time of diagnosis.

Camphor helps provide relief from various inflammations, such as muscle soreness, respiratory inflammation, joint ...

Psoriasis results in long-term inflammation in the body. This inflammation stiffens and narrows the arteries, raising the risk of high blood pressure, heart attack, and stroke. Read on. , Health News ...

Investigators compared outcomes among patients with psoriasis undergoing apremilast treatment with genital involvement versus those without genital involvement.

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found tildrakizumab outcomes to have a mean drug ...

A group of researchers have created four novel laboratory-developed tests that can distinguish between and subclassify atopic ...